Skip to main content
. 2019 Dec 23;7:342. doi: 10.3389/fcell.2019.00342

FIGURE 6.

FIGURE 6

ATRA increases the expression of MEG3 through the cAMP/CREB pathway to modulate neurogenic differentiation. (A) A siRNA for MEG3 (si-MEG3) effectively depressed the expression of MEG3 in induced AECs (P < 0.05). (B) The concentration of cAMP was detected between normal significantly increased in induced compared with normal AECs (P < 0.05). (C) Expression of cAMP response element-binding protein (CREB) was detected under ATRA or 666-15 (a CREB inhibitor) treatment using immunofluorescence staining. (D) MEG3 expression was analyzed under 666-15 or Jagged 1 treatment by RT-qPCR. (E,F) Expression of β III-tubulin and GFAP were as assessed using Western blotting. (G) β III-tubulin and GFAP expression was analyzed following single or assorted overexpression of MEG3 (o-MEG3), si-MEG3 or 666-15 treatment in induced AECs. iAECs, induced AECs; siMEG3-NC, siMEG3 negative control. P < 0.05; ∗∗P < 0.01; ns, non-significant.